Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of MenACWY-CRM (Menveo) in Healthy Subjects in South Korea
NCT01766206Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2013
- Primary completion
- Jan 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Meningococcal polysaccharide (serogroups A, C, W, and Y) tetanus toxoid conjugate vaccine in meningococcal disease, sponsored by GSK. Started Mar 2013; status: completed.
02
Drugs
Meningococcal polysaccharide (serogroups A, C, W, and Y) tetanus toxoid conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT01766206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01766206.